Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 2
2006 5
2007 2
2008 6
2009 3
2010 2
2011 4
2012 6
2013 4
2014 4
2015 6
2016 1
2017 2
2018 5
2019 8
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Results by year
Filters applied: . Clear all
Page 1
Tofacitinib for the treatment of psoriasis and psoriatic arthritis.
Berekmeri A, Mahmood F, Wittmann M, Helliwell P. Berekmeri A, et al. Among authors: wittmann m. Expert Rev Clin Immunol. 2018 Sep;14(9):719-730. doi: 10.1080/1744666X.2018.1512404. Expert Rev Clin Immunol. 2018. PMID: 30118353 Free article. Review.
Non-invasive Approaches for the Diagnosis of Autoimmune/Autoinflammatory Skin Diseases-A Focus on Psoriasis and Lupus erythematosus.
Berekméri A, Tiganescu A, Alase AA, Vital E, Stacey M, Wittmann M. Berekméri A, et al. Among authors: wittmann m. Front Immunol. 2019 Aug 21;10:1931. doi: 10.3389/fimmu.2019.01931. eCollection 2019. Front Immunol. 2019. PMID: 31497014 Free PMC article. Review.
The novel cytokine Metrnl/IL-41 is elevated in Psoriatic Arthritis synovium and inducible from both entheseal and synovial fibroblasts.
Bridgewood C, Russell T, Weedon H, Baboolal T, Watad A, Sharif K, Cuthbert R, Wittmann M, Wechalekar M, McGonagle D. Bridgewood C, et al. Among authors: wittmann m. Clin Immunol. 2019 Nov;208:108253. doi: 10.1016/j.clim.2019.108253. Epub 2019 Aug 27. Clin Immunol. 2019. PMID: 31470086
The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man.
Bridgewood C, Alase A, Watad A, Wittmann M, Cuthbert R, McGonagle D. Bridgewood C, et al. Among authors: wittmann m. Inflamm Res. 2019 Jun;68(6):423-426. doi: 10.1007/s00011-019-01235-x. Epub 2019 Apr 13. Inflamm Res. 2019. PMID: 30989239 Free PMC article.
Correction to: The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man.
Bridgewood C, Alase A, Watad A, Wittmann M, Cuthbert R, McGonagle D. Bridgewood C, et al. Among authors: wittmann m. Inflamm Res. 2019 Jun;68(6):427. doi: 10.1007/s00011-019-01242-y. Inflamm Res. 2019. PMID: 31065724 Free PMC article.
Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature.
Shalbaf M, Alase AA, Berekmeri A, Md Yusof MY, Pistolic J, Goodfield MJ, Edward S, Botchkareva NV, Stacey M, Vital EM, Wittmann M. Shalbaf M, et al. Among authors: wittmann m. Lupus Sci Med. 2019 Jul 14;6(1):e000328. doi: 10.1136/lupus-2019-000328. eCollection 2019. Lupus Sci Med. 2019. PMID: 31413850 Free PMC article.
Identification of myeloid cells in the human enthesis as the main source of local IL-23 production.
Bridgewood C, Watad A, Russell T, Palmer TM, Marzo-Ortega H, Khan A, Millner PA, Dunsmuir R, Rao A, Loughenbury P, Wittmann M, Cuthbert RJ, McGonagle DG. Bridgewood C, et al. Among authors: wittmann m. Ann Rheum Dis. 2019 Jul;78(7):929-933. doi: 10.1136/annrheumdis-2018-214944. Epub 2019 Apr 24. Ann Rheum Dis. 2019. PMID: 31018959 Free PMC article.
Regression of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated With Ustekinumab for Moderate-to-Severe Chronic Plaque Psoriasis: A Fifty-Two-Week, Prospective, Open-Label Feasibility Study.
Savage L, Goodfield M, Horton L, Watad A, Hensor E, Emery P, Wakefield R, Wittmann M, McGonagle D. Savage L, et al. Among authors: wittmann m. Arthritis Rheumatol. 2019 Apr;71(4):626-631. doi: 10.1002/art.40778. Epub 2019 Mar 4. Arthritis Rheumatol. 2019. PMID: 30468001 Free article. Clinical Trial.
Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis.
Savage LJ, Wittmann M, McGonagle D, Helliwell PS. Savage LJ, et al. Among authors: wittmann m. Rheumatol Ther. 2015 Jun;2(1):1-16. doi: 10.1007/s40744-015-0010-2. Epub 2015 Mar 17. Rheumatol Ther. 2015. PMID: 27747495 Free PMC article. Review.
Cytokines as therapeutic targets in skin inflammation.
Wittmann M, McGonagle D, Werfel T. Wittmann M, et al. Cytokine Growth Factor Rev. 2014 Aug;25(4):443-51. doi: 10.1016/j.cytogfr.2014.07.008. Epub 2014 Aug 1. Cytokine Growth Factor Rev. 2014. PMID: 25164568 Review.
63 results
Jump to page
Feedback